Abstract: A processing system may obtain baseline attributes associated with a plurality of representative files of a first type of network equipment, where the baseline attributes comprise a plurality of baseline checksums associated with the plurality of representative files, obtain snapshot attributes associated with a first plurality of files of a first device deployed in a communication network, where the first device is of the first type of network equipment, and where the first plurality of files is associated with at least a portion of the plurality of representative files, identify at least one file of the first plurality of files or at least one directory associated with the first plurality of files, for which a respective one of the snapshot attributes fails to match a respective one of the baseline attributes, and perform at least one remedial action in the communication network in response to the identifying.

Abstract: A processing system may obtain baseline attributes associated with a plurality of representative files of a first type of network equipment, where the baseline attributes comprise a plurality of baseline checksums associated with the plurality of representative files, obtain snapshot attributes associated with a first plurality of files of a first device deployed in a communication network, where the first device is of the first type of network equipment, and where the first plurality of files is associated with at least a portion of the plurality of representative files, identify at least one file of the first plurality of files or at least one directory associated with the first plurality of files, for which a respective one of the snapshot attributes fails to match a respective one of the baseline attributes, and perform at least one remedial action in the communication network in response to the identifying.

Abstract: A processing system may obtain baseline attributes associated with a plurality of representative files of a first type of network equipment, where the baseline attributes comprise a plurality of baseline checksums associated with the plurality of representative files, obtain snapshot attributes associated with a first plurality of files of a first device deployed in a communication network, where the first device is of the first type of network equipment, and where the first plurality of files is associated with at least a portion of the plurality of representative files, identify at least one file of the first plurality of files or at least one directory associated with the first plurality of files, for which a respective one of the snapshot attributes fails to match a respective one of the baseline attributes, and perform at least one remedial action in the communication network in response to the identifying.

Abstract: A combination bioactive silicate (e.g., bioactive glass) medicine carrier and shunt of one embodiment includes a shunt which is a tubular member made of bioactive silicate or glass being adapted to be bioresorbable and water soluble, or fiber bundle, the shunt including an insertion end at a first end. Gaps in the bioactive silicate or gaps in the glass adapted to be bioresorbable and water soluble are served as at least one storage for storing medicines.

Abstract: A shunt for draining ocular fluid of one embodiment includes a tubular body formed of a mesh material including bioactive glass fiber and collagen, the tubular body including an implantation member and a conduit through the implantation member. The implantation member and the conduit are formed integrally. Other embodiments are also contemplated.

Abstract: A combination bioactive silicate (e.g., bioactive glass) medicine carrier and shunt of one embodiment includes a shunt which is a tubular member made of bioactive silicate or glass being adapted to be bioresorbable and water soluble, or fiber bundle, the shunt including an insertion end at a first end. Gaps in the bioactive silicate or gaps in the glass adapted to be bioresorbable and water soluble are served as at least one storage for storing medicines.

Abstract: The present invention provides an isolated cell composition, which in some embodiments is suitable for adoptive immunotherapy, as well as methods of manufacturing the cell compositions and methods of treatment with the cell compositions. The composition comprises, in a pharmaceutically acceptable carrier, at least about 106 CD8+ T cells specific for target peptide antigen(s), which comprises T memory stem (TSCM) cells. In various embodiments, the composition is from about 1% to about 100% T memory stem cells, providing for a robust and durable adoptive therapy, as well as providing for T cell engineering advances.

Abstract: A shunt for draining ocular fluid of one embodiment includes a tubular body formed of a mesh material including bioactive glass fiber and collagen, the tubular body including an implantation member and a conduit through the implantation member. The implantation member and the conduit are formed integrally. Other embodiments are also contemplated.

Abstract: The present invention provides an isolated cell composition, which in some embodiments is suitable for adoptive immunotherapy, as well as methods of manufacturing the cell compositions and methods of treatment with the cell compositions. The composition comprises, in a pharmaceutically acceptable carrier, at least about 106 CD8+ T cells specific for target peptide antigen(s), which comprises T memory stem (TSCM) cells. In various embodiments, the composition is from about 1% to about 100% T memory stem cells, providing for a robust and durable adoptive therapy, as well as providing for T cell engineering advances.

Abstract: The present invention provides an isolated cell composition, which in some embodiments is suitable for adoptive immunotherapy, as well as methods of manufacturing the cell compositions and methods of treatment with the cell compositions. The composition comprises, in a pharmaceutically acceptable carrier, at least about 106 CD8+ T cells specific for target peptide antigen(s), which comprises T memory stem (TSCM) cells. In various embodiments, the composition is from about 1% to about 100% T memory stem cells, providing for a robust and durable adoptive therapy, as well as providing for T cell engineering advances.